| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-06 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-05 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | 0.11 | 0.0004 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.11 | 0.0006 |
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Epothilone B | FIMM | pan-cancer | AAC | -0.52 | 0.001 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.15 | 0.001 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.4 | 0.002 |